Ticker Launch

SPAC · Merger completed

Amplitude Healthcare Acquisition Corp

Business combination with Jasper Therapeutics, Inc.

Amplitude Healthcare Acquisition Corp is a blank-check company (SPAC) that raised $100M in its initial public offering on Nov 21, 2019, listing on NYSE. It completed its business combination with Jasper Therapeutics, Inc. on Sep 24, 2021; the combined company is Jasper Therapeutics, Inc. (JSPR). American Express Company led the IPO, with Morgan Stanley and Bone. Ellenoff Grossman & Schole advised the SPAC and Mayer Brown advised the underwriters on the IPO.

Jasper Therapeutics is a biotechnology company developing curative therapies based on hematopoietic stem cell biology. Its lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing hematopoietic cell transplantation.

Status
Merger completed
IPO date
Nov 21, 2019
IPO size
$100M
IPO exchange
NYSE
Target
Jasper Therapeutics, Inc. (Old Jasper)
Announced
May 6, 2021
Stated deal value
$490M
Closed
Sep 24, 2021
Combined company
Jasper Therapeutics, Inc. (JSPR)
IPO underwriters
American Express Company, Morgan Stanley, Bone and Collegium Pharmaceuticals
SPAC counsel (IPO)
Ellenoff Grossman & Schole
Underwriters' counsel (IPO)
Mayer Brown

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021